Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eom Pharmaceutical Holdings Inc (IMUC)

Eom Pharmaceutical Holdings Inc (IMUC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 0
  • Shares Outstanding, K 0
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,310 K
  • 60-Month Beta 0.38
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade IMUC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/30/19
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0730 +64.79%
on 08/21/24
0.1690 -28.82%
on 09/03/24
-0.0346 (-22.34%)
since 08/16/24
3-Month
0.0720 +67.08%
on 06/20/24
0.1900 -36.68%
on 06/21/24
-0.0697 (-36.68%)
since 06/17/24
52-Week
0.0720 +67.08%
on 06/20/24
0.3999 -69.92%
on 01/10/24
-0.1597 (-57.04%)
since 09/18/23

Most Recent Stories

More News
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil

/PRNewswire/ -- EOM Pharmaceutical Holdings, Inc (OTC: IMUC) ("EOM") today announced the results of its completed clinical trial in hospitalized COVID-19...

IMUC : 0.1203 (+2.47%)

Business Summary

EOM Pharmaceuticals Inc. is a privately held, clinical-stage pharmaceutical company. It focus on advancing novel immunomodulatory and retinal disease drug agents to address a range of inflammatory, viral, retinal and other diseases. EOM Pharmaceuticals Inc., formerly known as ImmunoCellular Therapeutics...

See More

Key Turning Points

3rd Resistance Point 0.1498
2nd Resistance Point 0.1439
1st Resistance Point 0.1321
Last Price 0.1203
1st Support Level 0.1144
2nd Support Level 0.1085
3rd Support Level 0.0967

See More

52-Week High 0.3999
Fibonacci 61.8% 0.2746
Fibonacci 50% 0.2359
Fibonacci 38.2% 0.1973
Last Price 0.1203
52-Week Low 0.0720

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar